Reimbursing Patients for Participation in Cancer Clinical Trials

被引：2

作者：

Unger, Joseph M. ^{[1
]}

Fleury, Mark E. ^{[2
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M3-C102,POB 19024, Seattle, WA 98109 USA

[2] Amer Canc Soc, Canc Act Network Inc, Washington, DC USA

来源：

JAMA ONCOLOGY | 2019年 / 5卷 / 07期

关键词：

D O I：

10.1001/jamaoncol.2019.0141

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：932 / 934

页数：4

共 8 条

[1]

[Anonymous], 2010, NATL CANC CLIN TRIAL

[2]

[Anonymous], BARR PAT ENR THER CL

[3] What's the price of a research subject? Approaches to payment for research participation [J].

Dickert, N ;

Grady, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :198-203

[4]

Largent Emily A, 2017, IRB, V39, P1

[5]

U.S. Census Bureau, CURR POP SURV 1968 2

[6] Patient Income Level and Cancer Clinical Trial Participation [J].

Unger, Joseph M. ;

Hershman, Dawn L. ;

Albain, Kathy S. ;

Moinpour, Carol M. ;

Petersen, Judith A. ;

Burg, Kenda ;

Crowley, John J. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) :536-542

[7]

US Food and Drug Administration, PAYM REIMB RES SUBJ

[8] Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement [J].

Winkfield, Karen M. ;

Phillips, Jonathan K. ;

Joffe, Steven ;

Halpern, Michael T. ;

Wollins, Dana S. ;

Moy, Beverly .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (33) :3331-+

← 1 →